Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.
4 trials since 2013, 1 ongoing, by the sponsor of the products; see every authorized trial
A phase 3, 24-week, randomized, double-blind, placebo-controlled, parallelarm efficacy and safety study with open-label…Feb 11, 2025 · Ongoing · Camlipixant (GSK5464714, BLU-5937)
A phase 3, 52-week, randomized, double-blind, placebo-controlled, parallel-arm efficacy and safety study with…Nov 16, 2022 · Closed · Camlipixant (BLU-5937)
A randomized, adaptive, double-blind, placebo-controlled, parallel-arm, phase 2b study to evaluate the efficacy and…Jan 12, 2021 · Closed · BLU-5937
A randomized, double-blind, placebo-controlled, parallel study to evaluate the efficacy, safety, and tolerability of…Feb 18, 2020 · Closed · BLU-5937
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata.